Keyphrases
Obesity
100%
Polycystic Ovary Syndrome
83%
Obstetrician-gynecologists
76%
Patient Survey
74%
Pregnancy Outcome
49%
Anti-obesity
43%
Septic Abortion
37%
Receptor Agonist
37%
Patient Care
37%
Primary Care Physicians
37%
Weight Loss
37%
Glucagon-like
37%
Noninvasive Prenatal Screening
37%
Invasive Prenatal Testing
37%
A1 Receptor
37%
COVID-19
37%
Umbilical Cord Blood
37%
Expectant Management
37%
Endometrial Ablation
37%
Computational Model
37%
Placenta Accreta
37%
Delivery Time
37%
Obese Population
37%
Vaccination in Pregnancy
37%
Molar Pregnancy
37%
Chronic Opioid Use
37%
Fetal Vessels
37%
Coexisting Fetus
37%
Fetal Nasal Bone Length
37%
Velamentous Umbilical Cord Insertion
37%
Obstetric Hemorrhage
37%
During Pregnancy
37%
East African
37%
African Ancestry
37%
United States
33%
Hydatidiform
31%
Health Care Costs
29%
Cesarean Delivery
29%
Liraglutide 3.0 Mg
27%
Neonate
27%
Fetus
25%
Stillbirth
22%
Worst-case Model
22%
Management Strategy
21%
Women of Reproductive Age
21%
Obesity Management
19%
Pregnancy Complications
18%
Fetal Management
18%
Fetal Risk
18%
Narcotic Use
18%
Medicine and Dentistry
Polycystic Ovary Syndrome
83%
Cross Sectional Study
78%
Primary Health Care
46%
Cesarean Section
38%
Nasal Bone
37%
Molar Pregnancy
37%
Glucagon-Like Peptide-1 Agonist
37%
Severe Acute Respiratory Syndrome Coronavirus 2
37%
Prenatal Screening
37%
Cord Blood
37%
Health Care Cost
37%
Septic Abortion
37%
Fetal Hemorrhage
37%
Fetus Risk
37%
Prenatal Care
37%
Methadone
37%
Puerperium
37%
Narcotic Dependence
37%
Intrapartum
37%
Substitution Therapy
37%
Liraglutide
37%
Placenta Accreta
37%
Buprenorphine
37%
Umbilical Cord
37%
Endometrial Ablation
37%
Fetomaternal Transfusion
37%
Neonates
33%
Stillbirth
29%
Obstetrics
19%
Pregnancy Complication
18%
Placenta
18%
Obesity Management
17%
Genetic Screening
16%
Third Trimester Pregnancy
14%
Vaginal Delivery
14%
Health Care
14%
Assisted Reproductive Technology
10%
Trophoblastic Disease
10%
Gestational Age
9%
Gynecology
9%
Gastrointestinal Distress
9%
Erythrocyte Transfusion
9%
Food Intake
9%
Fetal Heart Rate
9%
Vasa Previa
9%
Clinical Trial
9%
Breast Cancer
9%
Vagina Bleeding
9%
Bleeding
9%
Chronic Disease
9%
